Skip to main content

Table 2 Comparison of treatment induced changes in both groups

From: High efficacy of low-dose albumin infusion in the prevention of paracentesis-induced circulatory dysfunction

 Low-dose albuminStandard-dose albuminp
N = 85N = 25
Δ Weight, kg− 4.35 ± 7.02− 10.64 ± 3.670.001#
Δ MAP, mmHg− 1.59 ± 9.29− 1.19 ± 6.090.699#
Δ Heart rate, beat/minute2.07 ± 14.140.80 ± 3.180.523#
Δ Total bilirubin, mg/dL0.15 ± 0.890.12 ± 0.590.756#
Δ Total protein, g/dL− 0.12 ± 0.49− 0.28 ± 0.850.249
Δ Albumin, g/dL− 0.01 ± 0.192.35 ± 11.560.65#
Δ AST, U/L− 0.95 ± 24.650.80 ± 25.020.756
Δ ALT, U/L− 2.34 ± 24.982.44 ± 12.100.358
Δ ALP, U/L− 12.06 ± 114.57− 31.12 ± 106.930.46
Δ GGT, U/L− 1.72 ± 20.57− 7.86 ± 72.380.486
Δ Urea, mg/dL14.96 ± 23.843.72 ± 10.620.005#
Δ Creatinine, mg/dL0.14 ± 0.350.06 ± 0.290.348#
Δ Sodium, mmol/L−1.84 ± 17.39− 2.72 ± 1.430.8
Δ Potassium, mmol/L0.07 ± 0.69− 0.14 ± 0.640.166
Δ MELD0.79 ± 3.460.12 ± 1.590.145#
Δ PRA, pg/mL281.95 ± 851.426.28 ± 30.20.102#
PRA percent increase10.97 ± 30.7712.57 ± 14.870.844#
  1. Δ indicates day 6 values to day 1 value
  2. MAP mean arterial pressure, PRA plasma renin activity
  3. #Mann–Whitney U test